Curtana Pharmaceuticals Company
Curtana is a biopharmaceutical company that has developed therapies for the treatment of the most aggressive types of brain cancer.
Investors Number:
3
Last Funding Date:
2017
Technology:
Small Molecules
Total Funding:
52288
Founded Date:
2013
Headquarters:
Austin, Texas, United States
Employee Number:
1-10
Estimated Revenue:
Less than $1M
Last Funding Type:
Grant
Investor Type:
Seed
Funding Status:
Seed
Industry:
Biopharma, Biotechnology, Pharmaceutical